Plasmacytoid dendritic cells in the immunological context of TP53-mutated high-grade serous ovarian carcinoma
Steger, K.; Fiegl, H.; Rungger, K.; Leitner, K.; Tsibulak, I; Feroz, B.; Ebner, C.; Marth, C.; Hackl, H.; Zeimet, A. G..png)
Share.png)
Save Torque tenovirus (TTV) in gynecological oncology: Prognostic value in patients with epithelial ovarian carcinomaZommer, P.; Pan, T. L.; Onoprienko, A.; Strassl, R.; Breuer, M.; Bond, G.; Doberer, K.; Ralser, D.; Polterauer, S.; Bartl, T. Share Save Neoadjuvant endocrine therapy and histopathological changes in breast cancer - a retrospective analysisBurger, O.; Vietzen, H.; Singer, C. F.; Tendl-Schulz, K. A.; Bago-Horvath, Z.; Pfeiler, G.; Gschwantler-Kaulich, D.; Leser, C.; Deutschmann, C.; Seifert, M.; Danzinger, S. Share Save Efficacy and safety of anthracycline-based chemotherapy and dual HER2 blockade in early HER2-positive breast cancer: a retrospective analysisEmmelheinz, M.; Reimer, D.; Brunner, C.; Reiner, A.; Toth, S.; Knoll, K.; Purtscheller, R.; Albertini, C.; Unterthurner, J.; Egle, D. Share Save Real-world efficacy of palbociclib plus endocrine therapy in first-line and subsequent treatments in patients with HR+/HER2-advanced breast cancer: interim results from the PERFORM trialPfeiler, G.; Bartsch, R.; Korell, M.; Gabrysiak, T.; Petersen, V; Deryal, M.; Fietz, T.; Radosa, J.; Decker, T.; Schoettker, B.; Knoblich, J.; Rhein, U.; Deuerling, N.; Glasstetter, M.; Gratzke, K.; Buder, A.; Lunglmeir, K.; Czachorowski, M.; Dzieran, J.; Lux, M. P. Share Save Retrospective descriptive analysis of the No specific molecular pattern (NSMP) subgroup of endometrial cancerPolt, Y.; Sieghartsleitner, E.; Trutnovsky, G.; Stroisch, F.; Geissler, F.; Schmidt, M.; Kohlen, M.; Tamir, S.; Praetorius, T.; Flethe, C.; Sehouli, J.; Pietzner, K. Share Save 
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
